Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5196909
Max Phase: Preclinical
Molecular Formula: C31H40N6O10
Molecular Weight: 656.69
Associated Items:
ID: ALA5196909
Max Phase: Preclinical
Molecular Formula: C31H40N6O10
Molecular Weight: 656.69
Associated Items:
Canonical SMILES: C[C@H](NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](OCc2ccccc2)[C@@H]1N=[N+]=[N-])C(=O)N[C@H](CCC(=O)OCc1ccccc1)C(N)=O
Standard InChI: InChI=1S/C31H40N6O10/c1-18(29(42)35-22(28(32)41)13-14-24(39)44-16-20-9-5-3-6-10-20)34-30(43)19(2)46-27-25(36-37-33)31(47-23(15-38)26(27)40)45-17-21-11-7-4-8-12-21/h3-12,18-19,22-23,25-27,31,38,40H,13-17H2,1-2H3,(H2,32,41)(H,34,43)(H,35,42)/t18-,19+,22+,23+,25+,26+,27+,31-/m0/s1
Standard InChI Key: ZKISXNRYVNDSQA-FBDJJGPPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 656.69 | Molecular Weight (Monoisotopic): 656.2806 | AlogP: 0.73 | #Rotatable Bonds: 17 |
Polar Surface Area: 244.50 | Molecular Species: ACID | HBA: 11 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -10.30 | CX Basic pKa: | CX LogP: 0.58 | CX LogD: 0.47 |
Aromatic Rings: 2 | Heavy Atoms: 47 | QED Weighted: 0.07 | Np Likeness Score: 0.66 |
1. Reddy PRS, Sambyal S, Mhamane TB, Sravanthi V, Shafi S, Khan IA, Sampath Kumar HM.. (2022) Synthesis and biological evaluation of novel 2-azido muramyl dipeptide as NOD2 agonistic adjuvants., 66 [PMID:35569249] [10.1016/j.bmc.2022.116781] |
Source(1):